NCT06692062
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +10 more
- Locations
-
- Xiangya Hospital, Central South University Changsha, Hunan, China
Clinical trial condition
Neoplasms, Complex and Mixed
Explore clinical trials studying Neoplasms, Complex and Mixed. Study availability and eligibility vary by location and protocol.
402 public trials
77 recruiting studies
Neoplasms, Complex and Mixed trial results
NCT05214612
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Hemic and Lymphatic Diseases, +24 more
- Locations
-
- Assiut University Asyut, Egypt
NCT06301945
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +10 more
- Locations
-
- Erasmus MC Rotterdam, South Holland, Netherlands
Recruiting
Robot-assisted vs VATS for Thymoma
NCT06029621
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +6 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
- The Second Affiliated Hospital Zhejiang University School of Medicine Zhejiang, China
NCT05832827
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- National Cancer Center Hospital Chūō, Tokyo, Japan
Recruiting
National Registry of Rare Kidney Diseases
NCT06065852
- Conditions
- AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more
- Locations
-
- Zoe Plummer Bristol, South West, United Kingdom
NCT04822077
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
- Locations
-
- Department of Oncology, Norrlands Universitetssjukhus Umeå, Norrland, Sweden
- Department of Oncology, Karolinska University Hospital Stockholm, Stockholm County, Sweden
- Department of Oncology, Sahlgrenska University Hospital Gothenburg, Västra Götaland County, Sweden
Not yet recruiting
Clinical Genetics Branch Eligibility Screening Survey
NCT07005297
- Conditions
- Abnormalities, Multiple, Anemia, Anemia, Aplastic, +44 more
- Locations
-
- National Cancer Institute Rockville, Maryland, United States
Not yet recruiting
A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas
NCT07750353
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center Yokohama, Kanagawa, Japan
- Osaka International Cancer Institute Chuo-ku, Osaka, Japan
- National Cancer Center Hospital Chuo-ku, Tokyo, Japan
Not yet recruiting
Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial
NCT07723235
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +21 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States